Overview

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

Status:
Active, not recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Multicenter, double-blind study comparing SLI-F06 to vehicle formulation buffer for the improvement in scar appearance and wound strength in routine surgical excisions, as well as post-operative abdominoplasty scar appearance.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Scarless Laboratories, Inc.
Collaborator:
ethica Clinical Research Inc.